^
Association details:
| Biomarker: | APC mutation |
|---|---|
| Cancer: | Colorectal Cancer |
| Drug: | Avastin (bevacizumab) (VEGF-A inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer
Published date:
09/25/2023
Excerpt:
APC mutation status was a significantly enriched factor in responders to bevacizumab treatment.
DOI:
10.32604/or.2023.030374
